Attachment 7: Diagnosis-Restricted  Drugs

(Organized by Diagnosis Code Description)

PDF (176 KB)

Back to the beginning of this Update

The following table lists diagnosis-restricted drug categories and the corresponding diagnosis codes and disease descriptions. When a prescription is written for a diagnosis listed in this attachment, prior authorization (PA) is not required. For uses outside the listed diagnoses, PA is required. Submission of peer-reviewed medical literature to support the proven efficacy of the requested use of the drug is also required.

Note: This table includes Wisconsin Medicaid’s most current information and may be updated periodically. All drugs listed in the "Brand Name" column of this table are registered or trademarked by the manufacturer.

Diagnosis Code Description

Diagnosis Code

Generic Drug
Name

Brand Name

Non-Steroidal Anti-Inflammatory Drug (NSAID)-induced gastric ulcer
NSAID-induced duodenal ulcer

E9356

 

Omeprazole

Prilosec OTC 20 mg tablets

H. Pylori infection

04186

Zollinger-Ellison syndrome

2515

Erosive esophagitis

53019

Gastroesophageal reflux

53081

Gastric hypersecretory conditions

5368

NSAID-induced gastric ulcer
NSAID-induced duodenal ulcer

E9356

Lansoprazole

Prevacid Suspension

H. Pylori infection

04186

Zollinger-Ellison syndrome

2515

Erosive esophagitis

53019

Gastroesophageal reflux

53081

Gastric hypersecretory conditions

5368

NSAID-induced gastric ulcer
NSAID-induced duodenal ulcer

E9356

Misoprostol

Cytotec

H. Pylori infection

04186

Lansoprazole/
Antibiotic

Prevpac

Gaucher’s Disease

2727

Alglucerase

Ceredase, Cedezyme

Gaucher’s Disease

2727

Miglustat

Zavesca

Anemia from Acquired Immune Deficiency Syndrome (AIDS)

042

Epoetin

Epogen, Procrit

Renal failure

585

Malignancy

2399

Renal failure

585

Darbopoetin Alfa in Albumin Solution

Aranesp

Chronic hepatitis C without hepatic coma

07054

Interferon Alfa 2A

Roferon-A

Malignant melanoma

1729

Kaposi’s sarcoma

1760-1769

Hairy cell leukemia

2024

Non-Hodgkin’s lymphoma

2028

Multiple myeloma

2030

Chronic myelocytic leukemia

2051

Bladder carcinoma

2337

Renal cell carcinoma

2339

Chronic hepatitis C without hepatic coma

07054

Interferon Alfa 2B

Intron A

Condylomata acuminata

07811

Malignant melanoma

1729

Kaposi’s sarcoma

1760-1769

Hairy cell leukemia

2024

Non-Hodgkin’s lymphoma

2028

Multiple myeloma

2030

Bladder carcinoma

2337

Renal cell carcinoma

2339

Chronic hepatitis C without hepatic coma

07054

Peginterferon Alfa-2A

Pegasys

Chronic hepatitis C without hepatic coma

07054

Peginterferon Alfa-2B

Peg-Intron

Condylomata acuminata

07811

Interferon Alfa N3

Alferon N

Chronic granulomatous disease

2881

Interferon Gamma 1B

Actimmune

Osteopetrosis

75652

Chronic hepatitis C without hepatic coma

07054

Interferon Alfacon 1

Infergen

Chronic hepatitis C without hepatic coma

07054

Interferon Alfa 2B/Ribavirin

Rebetron

Chronic hepatitis C without hepatic coma

07054

Ribavirin

Copegus

Chronic hepatitis C without hepatic coma

07054

Ribavirin

Rebetol

Multiple sclerosis

340

Interferon Beta 1A

Avonex

Multiple sclerosis

340

Interferon Beta 1B

Betaseron

Multiple sclerosis

340

Interferon Beta 1A, Albumin

Rebif

Agranulocytosis/Neutropenia

2880

Filgrastim

Neupogen

Agranulocytosis/Neutropenia

2880

Pegfilgrastim

Neulasta

Myeloid leukemia

205

Sargramostim

Leukine

Impetigo

684

Mupirocin

Bactroban 2 percent

Organ transplant rejection

9968

Muromonab CD3

Orthoclone OKT-3

Nicotine dependence treatment

3051

Bupropion

Zyban

Nicotine dependence treatment

3051

Nicotine

Prostep, Habitrol

Blepharospasm

33381

Botulinum Toxin Type A

Botox

Spasmodic Torticollis

33383

Strabismus

3780-37887

Spasmodic Torticollis

33383

Botulinum Toxin Type B

Myobloc

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Methylphenidate

Concerta
Metadate
Ritalin
Ritalin LA
Methylin
Methylin ER
Methylphenidate Methylphenidate ER

Attention Deficit Disorder without mention of hyperactivity

31400

Attention Deficit Disorder with hyperactivity (ADHD)

31401

Narcolepsy and Cataplexy

347

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Dexmethylphenidate

Focalin

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Dextroamphetamines

Dexedrine
Dextrostat
Dextroamphetamine

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Narcolepsy and Cataplexy

347

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Amphetamines

Adderall
Adderall XR
Amphetamine Salts

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Narcolepsy and Cataplexy

347

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Methamphetamines

Desoxyn

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Obesity

278

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Atomoxetine HCl

Strattera

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Narcolepsy and Cataplexy

347

Modafinil

Provigil

Obstructive sleep apnea, hypopnea, and shift-work sleep disorder 78057

Hyperkinetic syndrome of childhood — Attention Deficit Disorder

314

Pemoline

Cylert
Pemoline

Attention Deficit Disorder without mention of hyperactivity

31400

ADHD

31401

Anemia in end-stage renal disease

28521

Legend Renal Care Vitamins

Renax
Diatx
Diatx FE
Nephrovite
Dialyvite

Chronic renal failure

585

Disorders resulting from impaired renal function

588

Unspecified disorder resulting from impaired renal function

5889

Normal pregnancy

V22-V222

Legend Prenatal Vitamins

 

High-risk pregnancy

V23-V239

Lactating

V241


Attachment 1: Brand Medically Necessary Drugs That Require Prior Authorization
Attachment 2: Brand Medically Necessary Prior Authorization Documentation
Attachment 3: MedWatch Reporting Form (FDA Web site) (PDF, 53 KB)
Attachment 4: Specialized Transmission Approval Technology-Prior Authorization (STAT-PA) Drugs
Attachment 5: Drug Products Requiring Paper Prior Authorization
Attachment 6: Diagnosis-Restricted Drugs (Organized by Generic Drug Name)
Attachment 8: Covered Over-the-Counter Drugs
Attachment 9: Noncovered Drugs
Attachment 10: Age- and Gender-Restricted Drugs
Attachment 11: Covered Over-the-Counter Drugs for HealthCheck "Other Services"
Attachment 12: Comparison of Wisconsin Medicaid and Wisconsin SeniorCare Policies
Attachment 13: Obsolete 1/1/05: STAT-PA Drug Worksheet for Brand Name Clozaril® — Use Prior Authorization / Brand Medically Necessary Attachment (PA/BMNA) (fillable PDF, 225 KB)  | Instructions (PDF, 71 KB)